Nicotinamide mononucleotide attenuates glucocorticoid-induced osteogenic inhibition by regulating the SIRT1/PGC-1α signaling pathway

Long-term and high-dose glucocorticoid treatment is recognized as an important influencing factor for osteoporosis and osteonecrosis. Nicotinamide mononucleotide (NMN) is an intermediate of NAD(+) biosynthesis, and is widely used to replenish the levels of NAD(+). However, the potential role of NMN...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Rui-Xiong, Tao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248519/
https://www.ncbi.nlm.nih.gov/pubmed/32377728
http://dx.doi.org/10.3892/mmr.2020.11116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248519/
https://www.ncbi.nlm.nih.gov/pubmed/32377728
http://dx.doi.org/10.3892/mmr.2020.11116

Ejemplares similares